Compound information
- Natural Products
- ZC948237
- Molecular Formula
- C17H19N3O3S
- Molecular Weight
- 345.114712468 g/mol
- Structure
-
- IUPAC Name
- (3R)-3-(benzenesulfonamido)-N-phenyl-pyrrolidine-1-carboxamide
- InChI
- InChI=1S/C17H19N3O3S/c21-17(18-14-7-3-1-4-8-14)20-12-11-15(13-20)19-24(22,23)16-9-5-2-6-10-16/h1-10,15,19H,11-13H2,(H,18,21)/t15-/m1/s1
- InChI Key
- BLOVVWWIWJPQIC-OAHLLOKOSA-N
- SMILES
- O=C(Nc1ccccc1)N1CC[C@@H](NS(=O)(=O)c2ccccc2)C1
- Source
- ZINC000219600188
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 78.51 Å2 | LogP | 1.726 |
LogS | -3.229 | LogD | 2.001 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.028 | Pgp substrate | 0.992 |
HIA | 0.911 | F20 % | 0.99 |
F30 % | 0.706 | Caco-2 | -5.817 |
MDCK | -5.831 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.126 | PPB | 67.291 |
VD | 0.853 | Fu | 0.965 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.414 | CYP1A2 substrate | 0.614 |
CYP2A6 substrate | 0.606 | CYP2B6 substrate | 0.618 |
CYP2C19 inhibitor | 0.26 | CYP2C19 substrate | 0.755 |
CYP2C8 substrate | 0.689 | CYP2C9 inhibitor | 0.24 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.095 |
CYP2D6 substrate | 0.977 | CYP2E1 substrate | 0.912 |
CYP3A4 inhibitor | 0.036 | CYP3A4 substrate | 0.996 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.279 | CL | 0.84 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.024 | Hepatotoxicity | 0.856 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.144 |
FDAMDD | 0.495 | Skin Sensitization | 0.054 |
Carcinogenicity | 0.143 | Eye Corrosion | 0.002 |
Eye Irritation | 0.242 | Respiratory Toxicity | 0.631 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.074 | IGC50 | 3.161 |
LC50FM | 2.198 | LC50DM | -2.524 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.323 | NR-AR-LBD | 0.203 |
NR-AhR | 0.074 | NR-Aromatase | 0.027 |
NR-ER | 0.387 | NR-ER-LBD | 0.283 |
NR-PPAR-gamma | 0.214 | SR-ARE | 0.076 |
SR-ATAD5 | 0.366 | SR-HSE | 0.046 |
SR-MMP | 0.152 | SR-p53 | 0.029 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.